Articles From: Cellectar Biosciences to Host Conference Call on November 11th to Discuss Third Quarter 2014 Results and Provide Quarterly Update on Development Progress to Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV


SOLANA BEACH, Calif., Nov.
Sign-up for Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results investment picks
2014/11/6
A Kaplan survey of SAT takers* about college admissions test preference reveals a surprising fact: a third of these students decided to take the SAT instead of its alternative, the ACT, because of a widely held misconception: 33% of survey respondents believed that the SAT is more widely accepted by colleges than the ACT.
Sign-up for Kaplan Test Prep Survey: Majority of Students May Be Taking the SAT® Instead of the ACT® for the Wrong Reasons investment picks
RADNOR, Pa., Nov.
Sign-up for Actua Announces Third Quarter 2014 Financial Results investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences investment picks
Oplink Shareholders for Change (“OSC”), a group led by Engaged Capital, LLC (“Engaged Capital”) and Voce Capital Management LLC (“Voce Capital”), released today a letter to shareholders of Oplink Communications Inc. (“Oplink” or the “Company”) (NASDAQ:OPLK) highlighting the Board’s continued abandonment of their responsibility to call the Annual Meeting of shareholders.
Sign-up for Oplink Shareholders for Change (OSC) Release Letter to Fellow Shareholders investment picks
2014/11/6
SAN DIEGO , Nov.
Sign-up for Pfenex To Report Third Quarter 2014 Results and Provide Business Update on Thursday, November 13, 2014 investment picks
http://media.marketwire.com/attachments/201409/276763_pfs.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156300&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb Sets Third Quarter Conference Call for Wednesday, November 12, 2014 at 11:00 a.m. ET investment picks
DALLAS, Nov.
Sign-up for Speed Commerce Reports Fiscal Second Quarter 2015 Results investment picks
http://media.marketwire.com/attachments/200903/435497_coremarklogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156711&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Core-Mark Announces Third Quarter 2014 Financial Results, Increases Dividend investment picks
Bear State Financial, Inc. (“Bear State”) (NASDAQ: BSF), today reported earnings of $22.7 million and earnings per diluted common share of $0.75 in the third quarter of 2014, compared to earnings of $143,000 or $0.01 per diluted common share in the third quarter of 2013, a 15,757% increase.
Sign-up for Bear State Financial, Inc.: Record Third Quarter 2014 Results Show Substantial Earnings and Book Value Accretion From Recent Merger investment picks
DUBLIN, Calif., Nov.
Sign-up for Ross Stores Announces Third Quarter 2014 Earnings Release and Conference Call investment picks
2014/11/6
The fast casual segment remains the top performer in the restaurant sector, and will continue to lead activity and change.
Sign-up for Now Serving Growth in the Restaurant Sector investment picks
http://media.marketwire.com/attachments/201305/153545_PRLibertyLogo2c.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156941&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for Liberty Tax Service Creates New, Hispanic-Focused Brand -- SiempreTax+ investment picks
Orbitz Worldwide (OWW) reported on Thursday a third-quarter profit of $9 million, or 8 cents a share, down from $13 million, or 11 cents a share, in the year-earlier period.
Sign-up for Orbitz profit falls short of estimates investment picks
2014/11/6
Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC; BMV:GAP) (“the Company” or “GAP”) announced today preliminary terminal passenger traffic figures for the month of October 2014 compared to traffic figures for October 2013.
Sign-up for Grupo Aeroportuario Del Pacífico Reports Passenger Traffic Decrease of 3.1% for October 2014 investment picks
2014/11/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977266001&sourceType=1 http://www.ccnmatthews.com/logos/20090130-bcl200.jpg TORONTO, ONTARIO --
Sign-up for CCL Industries Reports Record Quarterly Earnings Per Share and Declares Dividend investment picks
2014/11/6
Juvenile organic quarter revenue growth of 5% with strong earnings improvement Recreational/Leisure revenue grows for third consecutive quarter Lerado platform positions Dorel for further juvenile global leadership EXCHANGES TSX: DII.B, DII.A MONTREAL , Nov.
Sign-up for Dorel Announces Improved Third Quarter Results investment picks
PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter and nine months ended September 30, 2014.
Sign-up for PharMerica Reports Third Quarter 2014 Results investment picks
2014/11/6
Accenture Federal Services has delivered an integrated enterprise resource planning system that will help the National Capitol Region Medical Directorate (NCR MD) manage healthcare services for one of the largest military markets in the nation.
Sign-up for Accenture Expands Army Financial System to Better Serve Military Health Community investment picks
2014/11/6
Seeking to improve and sustain its manufacturing capabilities to meet the growing demand for oil and gas production and power transmission equipment, GE Oil & Gas (NYSE: GE) today announced it plans to invest $60 million in expanding and modernizing its foundry operations in Lufkin, Texas.
Sign-up for GE Oil & Gas Planning $60M Investment in Lufkin, Texas, Foundry to Better Meet Global Demand for Well Production Equipment and Power Transmission Equipment investment picks
2014/11/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156900&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for FBC Deal With COCO-AMO Retail Presence With Purchase Order of $7,000 investment picks
GFI Shareholders Urged to Tender Their Shares NEW YORK , Nov.
Sign-up for BGC's All-Cash Tender Clearly Represents Superior Value For GFI Shareholders investment picks
Sparton Corporation (NYSE:SPA) has announced the completed transition of the Aubrey Group brand to Sparton.
Sign-up for Aubrey Group Brand Fully Transitions to Sparton Corporation investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today disclosed a development program for a P/neurokinin-1 (NK 1 ) receptor antagonist, which is used in the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (CINV). NK 1 receptor antagonists are administered in combination with a 5-HT 3 receptor antagonist for the prevention of CINV.
Sign-up for Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cellectar Biosciences to Host Conference Call on November 11th to Discuss Third Quarter 2014 Results and Provide Quarterly Update on Development Progress to Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent